Service Bots: The New Solution to a Labor Shortage?

 

Every one of us has, at some point or another, experienced the dreaded “let me put you on hold” when attempting to speak to customer service. Well, that may no longer be an issue in the future, as video and voice AI shopping and service assistance for brands and enterprises are rolling out. With this unique innovation, businesses may no longer need to fear future labor shortages. 

So, what are customer assistant bots, and how exactly can they benefit businesses when placed alongside real humans? 

On today’s episode of What Just Happened, Host Christine Russo speaks with Michael Riemer, CEO of Vocinity, about implementing AI and service assistants in the retail sector as a new form of customer service.  

When it comes to something expensive, such as workout equipment, the bot can be programmed to take one’s body type or workout goals into account. Then, the bot can show the best fit of equipment for that specific customer.  

Riemer described what the experience should entail: “Really being able to create an immersive, personalized journey where rather than typing and waiting, right, you’re asking questions, and you’re visually engaging with either the virtual human or video or image which just makes it a more engaging and informative conversation.” 

Russo and Riemer also discussed… 

  • Use cases for AI and service assistant bots 
  • How AI and service assistants can offload salespeople 
  • How bots free up time and money for businesses 

These assistant bots can even be implemented in the aisles of stores, not just on websites. “So one of the values that we bring is not only does it work on a mobile device, as well as on the web, but you can actually use it in stores as well, just by scanning a QR code that’s on any item or merchandise, and actually have the virtual assistant show up on your personal phone and ask any questions that you have rather than trying to find an associate in the store,” explained Riemer. 

Riemer is CEO of Vocinity, CONNECTpreneur Ambassador, Managing Partner of New Urbana, and careMESH advisor. He has a BA in Philosophy and Biology from the University of Rochester. He has publications on the Smart Industry Forum, Industry Today, and Smart Industry, amongst other high-profile publications.  

 

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More